MDClone is a software company based in Israel, specializing in healthcare software solutions. Founded in 2016, the company operates with a small team of 11 to 50 employees and has reported revenue of approximately 7.35 million USD. MDClone's expertise is reflected in its focus on data-driven healthcare insights, as evidenced by its published research, which includes a study on sex differences in colonoscopy indications and findings. This research, derived from a large multicenter database, explores variations in colonoscopy procedures between males and females, highlighting differences in indications such as abdominal pain, constipation, and anemia. The study also presents findings related to pathological outcomes, including the detection rates of colorectal cancer and polyps. While the document corpus is limited, MDClone's commitment to advancing healthcare analytics through software solutions is apparent in its research initiatives, which aim to enhance understanding of clinical practices and patient outcomes.